Bristol-Myers Squibb revenue and financials

BMY · NYSE · USD

$59.59+1.33%+$0.78

Close · October 6, 2026

In the fiscal year ended December 2025, Bristol-Myers Squibb reported revenue of $48.19B (−0.22% year over year). Net income was $7.05B, a net margin of 14.6%.

Annual revenue · 2025: $48.19B

$19.43B2016
$20.78B2017
$22.56B2018
$26.15B2019
$42.52B2020
$46.39B2021
$46.16B2022
$45.01B2023
$48.3B2024
$48.19B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: −0.22%; 2025 vs 2024
Net margin: 14.6%; 2024: -18.5%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	90,038	92,603	95,159	96,820	109,314	118,481	129,944	34,986	33,551	33,707
Current assets	29,390	29,780	31,770	27,273	33,262	30,192	29,354	17,716	14,854	13,704
Cash and equivalents	10,209	10,346	11,464	9,123	13,979	14,546	12,346	6,911	5,421	4,237
Short-term investments	464	513	816	130	3,242	—	—	—	—	—
Receivables	14,526	14,424	15,264	13,937	12,516	—	—	—	—	—
Inventory	2,690	2,557	2,662	2,339	2,095	—	—	—	—	—
Net property, plant and equipment	9,125	8,360	8,036	7,475	6,968	—	—	—	—	—
Goodwill	21,754	21,719	21,169	21,149	20,502	20,547	22,488	6,538	6,863	6,875
Other intangible assets	19,103	23,307	27,072	35,859	42,527	—	—	—	—	—
Long-term investments	2,492	2,056	2,063	2,187	2,713	—	—	—	—	—
Current liabilities	23,417	23,774	22,262	21,890	21,868	19,080	18,304	10,654	9,563	8,841
Accounts payable	3,575	3,602	3,259	3,040	2,949	—	—	—	—	—
Long-term debt	44,827	49,431	39,526	38,953	44,369	50,336	46,150	6,895	6,975	5,716
Total debt	47,139	51,200	41,464	40,717	—	—	—	—	—	—
Total liabilities	71,533	76,215	65,674	65,702	73,308	80,599	78,246	20,859	21,704	17,360
Total equity (incl. minority)	18,506	16,388	29,485	31,118	36,006	—	—	—	—	—
Retained earnings	16,896	14,912	28,766	25,503	23,820	—	—	—	—	—
Minority interest	33.0	53.0	55.0	57.0	60.0	—	—	—	—	—